Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Benjamin L. Palleiko currently holds 462,577 shares of PENWEST PHARMACEUTICALS CO (PPCO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benjamin L. Palleiko has been a net seller of PPCO stock. They have purchased $16.3K and sold $4.5M worth of shares.
Benjamin L. Palleiko's most recent insider trade was on Apr 17, 2026, when they sold 9,550 shares at $20.22 per share.
Benjamin L. Palleiko serves as Executive at PENWEST PHARMACEUTICALS CO (PPCO). They have executed 83 insider transactions totaling $4.5M over their tenure at the company.
Benjamin L. Palleiko holds the position of Executive at PENWEST PHARMACEUTICALS CO, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Benjamin L. Palleiko has shown a selling trading pattern, with $16.3K in total purchases and $4.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Benjamin L. Palleiko was on Jul 9, 2025, when they sold $517.4K worth of KALV shares. This transaction involved 32,979 shares at $15.69 per share.
Benjamin L. Palleiko currently owns 462,577 shares of PENWEST PHARMACEUTICALS CO (PPCO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Benjamin L. Palleiko's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Benjamin L. Palleiko has 83 Form 4 filings on record as an insider at PENWEST PHARMACEUTICALS CO.
Set alerts for Benjamin L. Palleiko and 40,000+ other insiders.